Sabba Stephen L — SEC Form 4 filings
SEC reporting owner CIK 1442372. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-07 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 7,072 shares, $1,303,204 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 2,145 shares @ $254.00 ($544,830) in LIGAND PHARMACEUTICALS INC, filed 2026-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC (LGND) | Director | 8 | — | 4 legs · 7,072 sh · $1,303,204 | 14 |
Form 4 filings — Sabba Stephen L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,145 @ $66.13 · Sale (S): 2,145 @ $254 · Option exercise (M): 2,145 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 836 @ $0 · Grant/award (A): 2,938 (derivative) @ $0 | EDGAR |
| 2026-03-25 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Sale (S): 1,000 @ $207.87 | EDGAR |
| 2026-03-05 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,034 @ $69.51 · Sale (S): 2,034 @ $201.50 · Option exercise (M): 2,034 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 1,209 @ $0 · Grant/award (A): 5,783 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,406 @ $52.30 · Option exercise (M): 2,406 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Grant/award (A): 1,252 @ $0 · Grant/award (A): 5,444 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | LIGAND PHARMACEUTICALS INC (LGND) | Option exercise (M): 2,893 @ $0 · Sale (S): 1,893 @ $74.30 · Option exercise (M): 2,893 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1442372 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →